Not finding it? Sign in to also search OpenAlex live.
-
Abstract 299: From factory to patient: In vivo -expressed biologics as a new paradigm for immunotherapy manufacturing.2026 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology RNA Interference and Gene Delivery
Dan Rocca, Philipp Tobias Meyer, Ina Rohleff, Eva Oswald, Namrata Jayanth, Christian Wessel Cobaugh, +6 more
0citations -
The MANGROVE Phase 2 Trial: Study Design and Baseline Characteristics of Patients With Autosomal Dominant Polycystic Kidney Disease2022 Journal of the American Society of Nephrology conference-abstract Biochemistry, Genetics and Molecular Biology Genetic and Kidney Cyst Diseases
Ron T. Gansevoort, Antonio Pisani, Miguel Hueso, Davinia Van den Bergh, Willem Hettema, Karine Muller, +2 more
1citations -
Adding eltrombopag to immunosuppressive treatment with cyclosporine as front-line therapy for moderate aplastic anemia improves trilineage hematologic response: One-year analysis of the randomised, placebo-controlled, double-blind Phase III trial eltrombopag for moderate aplastic anemia (EMAA Trial)2025 Blood conference-abstract Biochemistry, Genetics and Molecular Biology Blood disorders and treatments Open access
Britta Hoechsmann, Philippe Schafhausen, Fabian Beier, Michael Heuser, Joerg Westermann, Beatrice Drexler, +10 more
0citations -
Procedure for pooling clinical outcome data from DRUP-like clinical trials using the OMOP model.2025 Journal of Clinical Oncology conference-abstract Mathematics Statistical Methods in Clinical Trials
T.M. Kringelbach, Gro Live Fagereng, Gabriel Bratseth Stav, Maria Martin Agudo, Soemeya F. Haj Mohammad, Florentine A.J. Verbeek, +13 more
0citations -
Scaling up Biodiversity Genomics in Europe: From Fragmented Efforts to a Unified Infrastructure2026 conference-abstract Environmental Science Environmental DNA in Biodiversity Studies Open access
Dimitrios Koureas, Ana Casino, Robert Michael Waterhouse, Claúdio Ciofi, Pete Hollingsworth, Mara Lawniczak, +3 more
0citations